Cry for health:a quantitative evaluation of a hospital-based advocacy intervention for domestic violence and abuse by Halliwell, Gemma et al.
                          Halliwell, G., Dheensa, S., Fenu, E., Jones, S. K., Asato, J., Jacob, S., &
Feder, G. (2019). Cry for health: a quantitative evaluation of a hospital-based
advocacy intervention for domestic violence and abuse. BMC Health
Services Research, 19, [718 (2019)]. https://doi.org/10.1186/s12913-019-
4621-0
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1186/s12913-019-4621-0
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via BMC at
https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-019-4621-0 . Please refer to any
applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
RESEARCH ARTICLE Open Access
Cry for health: a quantitative evaluation of
a hospital-based advocacy intervention for
domestic violence and abuse
Gemma Halliwell1* , Sandi Dheensa1, Elisabetta Fenu2, Sue K. Jones3, Jessica Asato3, Suzanne Jacob3 and
Gene Feder1
Abstract
Background: Domestic violence and abuse (DVA) damages the health of survivors and increases use of healthcare
services. We report findings from a multi-site evaluation of hospital-based advocacy services, designed to support
survivors attending emergency departments and maternity services.
Methods: Independent Domestic Violence Advisors (IDVA) were co-located in five UK hospitals. Case-level data were
collected at T1 (initial referral) and T2 (case closure) from survivors accessing hospital (T1 N = 692; T2 N = 476)
and community IDVA services (T1 N = 3544; T2 N = 2780), used as a comparator. Measures included indicators
of sociodemographic characteristics, experience of abuse, health service use, health and safety outcomes. Multivariate
analyses tested for differences in changes in abuse, health and factors influencing safety outcomes. Health service use
data in the 6 months pre-and post- intervention were compared to generate potential cost savings by hospital IDVA
services.
Results: Hospital IDVAs worked with survivors less visible to community IDVA services and facilitated intervention at an
earlier point. Hospital IDVAs received higher referrals from health services and enabled access to a greater number of
health resources. Hospital survivors were more likely to report greater reductions in and cessation of abuse. No differences
were observed in health outcomes for hospital survivors. The odds of safety increased two-fold if hospital survivors
received over five contacts with an IDVA or accessed six or more resources / programmes over a longer period of
time. Six months preceding IDVA intervention, hospital survivors cost on average £2463 each in use of health services;
community survivors cost £533 each. The cost savings observed among hospital survivors amounted to a total of
£2050 per patient per year. This offset the average cost of providing hospital IDVA services.
Conclusions: Hospital IDVAs can identify survivors not visible to other services and promote safety through intensive
support and access to resources. The co-location of IDVAs within the hospital encouraged referrals to other health services
and wider community agencies. Further research is required to establish the cost-effectiveness of hospital IDVA services,
however our findings suggest these services could be an efficient use of health service resources.
Keywords: Domestic violence and abuse, Intimate partner violence, Advocacy, Healthcare response, Accident
and emergency (ED)
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Background
Domestic violence and abuse (DVA) is a public health
problem and challenge to clinical services. The estimated
cost of DVA to the United Kingdom (UK) is £23 billion
per year, including health costs to the NHS of £1.73 billion
[1]. DVA can include physical and sexual violence, coer-
cive, controlling and emotionally abusive behaviours,
economic restrictions, as well as harassment and stalking.
In England and Wales 27% of women and 17% of men
report lifetime experience of DVA [2]. Most severe and re-
peated assaults are directed at women, committed by male
partners within the context of an intimate relationship [3].
Intimate partner violence (IPV) can have life-long phys-
ical and mental health consequences [4]. The association
with mental health problems is strong, with survivors at
heightened risk of experiencing anxiety, depression,
suicidal behaviours and PTSD [5, 6]. The severe health
outcomes of IPV leads to increased use of healthcare
services (e.g., primary care, emergency departments (ED),
mental health) [7, 8]. As such, healthcare professionals are
uniquely positioned to identify and respond to disclosures
of abuse and have a crucial role to play in the prevention
and management of IPV [9]. However, evidence shows
that while 54% of all women presenting at ED are likely to
have lifetime experience of IPV, only 5% are identified by
healthcare professionals [10].
The role of healthcare services in addressing intimate
partner violence
Guidance from the National Institute for Health Care
Excellence (NICE) and the World Health Organisation
(WHO) recommends that survivors presenting with
indicators of IPV in healthcare settings should be asked
about abuse by trained healthcare professionals and
support for IPV should be integrated into health settings
[11, 12]. Yet, healthcare professionals often face barriers
in identifying abuse [13, 14]. This difficulty has been
attributed to lack of training, time restrictions, confiden-
tiality and autonomy, attitudes about IPV, as well as
discomfort and low confidence. Organisational factors
also play a part, including lack of resources and suitable
environments for disclosures, absence of policies and
protocols about IPV, unclear referral pathways and lack
of co-ordination between services [15, 16]. Integration of
support for IPV in healthcare settings remains slow and
few healthcare-based interventions for IPV have been
evaluated systematically, making it difficult for providers,
policymakers and researchers to understand how to
effectively intervene [13, 14].
Independent domestic violence advisors (IDVA) within
hospital settings
One approach to training healthcare professionals to
identify and respond to IPV is to offer survivors on-site
DVA advocacy services. Advocacy support for survivors
at highest risk of harm or fatality has been formally
recognised in the role of the Independent Domestic
Violence Advisor (IDVA). IDVAs risk assess, safety plan
and help survivors to access services. IDVAs’ work can
include advocacy at Multi-Agency Risk Assessment Con-
ferences (MARAC) as well as support with the criminal
and civil justice system, emergency housing, health and
wellbeing, finances, employment and immigration [17].
IDVA services sit independently of other agencies (e.g.,
police, refuge) and are designed to be delivered from the
point of crisis over a relatively short period of time,
before referral onwards to longer-term community ser-
vices (e.g., outreach services). Meta-analyses show that
advocacy for severe IPV can improve quality of life and
reduce physical abuse short-term, but there is limited
evidence of its impact on mental health outcomes [18].
Despite the increased likelihood of survivors attending
ED for the health-related consequences of IPV, few stud-
ies have evaluated the role of advocacy in hospitals.
Hyman [19] reported outcomes of a short advocacy
intervention (90 min, one contact with patient) delivered
in ED. Findings suggested advocacy reduced psycho-
logical distress at three to four-month follow-up, but not
PTSD symptomology. Two studies exploring the efficacy
of hospital IDVA services (located in gynaecology,
genitourinary medicine [GUM], HIV clinics and ED)
reported an increase in detection rates of DVA among
survivors, higher referrals to hospital IDVAs from health
services and improvements in healthcare professionals’
confidence in tackling the issue [20, 21]. However, exist-
ing studies have reported findings from single sites (e.g.,
one hospital) across varying healthcare contexts and lack
outcomes reported by survivors, cost analyses or follow-
up data.
Aim
We present findings from a multi-site evaluation of an
advocacy approach to supporting survivors of DVA in a
hospital setting, exploring its impact on improving ac-
cess to support, health outcomes and cost effectiveness.
Independent Domestic Violence Advisors (IDVAs) were
co-located within ED and maternity services in hospitals
across the UK during April 2012 to November 2015.
The key components of the role included: providing
immediate support and advice, risk assessment and safety
planning; referral into external services; partnership-work
with hospital departments and community agencies; and
training hospital staff about DVA. The evaluation sought
to answer the following research questions:
1. Who are the survivors accessing help through
hospital IDVA services (compared to community
IDVA services)?
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2. What do hospital IDVAs do (compared to those
based in the community)?
3. What impact on survivors’ risk, safety, health and
wellbeing do hospital IDVAs have (compared to
community IDVAs)?
4. What is the cost effectiveness of hospital IDVA
services?
This article presents analysis of quantitative datasets
reported by the original research ‘A Cry for Health: Why
we must invest in domestic abuse services in hospitals
[22]. A comparison group of survivors from community
IDVA services was employed to test differences between
outcomes for community and hospital IDVA services.
Data collection
Individuals accessing IDVA services were eligible for
inclusion in the sample if they wished to receive support
from an IDVA and had consented to the use of their
anonymised information for monitoring or research
purposes. There were five hospital IDVA services who
participated and five community IDVA services based
within specialist DVA agencies. Two datasets reflect case
level data collected from individuals who had accessed
either service.
Case-level dataset contained data relating to the geo-
graphical areas covered by the IDVA services. Data were
collected at two time points. Time 1 reflected intake at
IDVA services (T1N = 692 hospital; N = 3544 commu-
nity). T2 reflected the point at which there was a
planned case closure or when the client exited a service
(N = 476 hospital; N = 2780 community). Time 2 data
were available for 68.7% of the Time 1 hospital IDVA
sample and 78.4% of the community IDVA sample.
Sociodemographic and referral information. At Time 1
information was collected on participants’ gender, age,
sexual orientation, ethnicity, household income, preg-
nancy, children in the household, relationship status,
living arrangements. Information collected around the
complex needs and additional vulnerabilities of partici-
pants related to mental health concerns, substance use,
financial issues and disability. Referral information in-
cluded items such as who the original referrer was, from
which hospital department and the original presenting
issue. Referral forms were collected at Time 1, for hos-
pital survivors only (T1N = 198).
Safety. Data pertaining to DVA was recorded by
IDVAs at T1 (abuse occurring within the previous 3
months) and T2 (abuse experienced during the interven-
tion period). The Severity of Abuse Grid is an estab-
lished tool in DVA practice settings [23] documenting
the presence, severity and escalation of four types of
abuse (physical, sexual, harassment and stalking, jealous
coercive and controlling behaviour). Responses to the
presence of any type of abuse are indicated on a 3-point
ordinal scale (standard, moderate, high). Severity and
frequency are recorded on a 3-point ordinal scale (re-
duced, unchanged, worse). Participants own appraisal of
safety was self-reported at Time 2 on a single-item scale
reflecting ‘feelings of safety’ assessed on a 5-point ordinal
scale (much safer, somewhat safer, no change, less safe).
Cessation of abuse at exit was calculated by combining
responses to the Severity of Abuse Grid into ‘Yes’ or ‘No’
categories to indicate the presence of ongoing abuse.
Health outcomes dataset included a sub-sample of hos-
pital and community IDVA participants who provided
information about their physical and mental health. Data
were collected at two time points. Time 1 reflected intake
IDVA service (T1N = 114 hospital; N = 86 community).
Time 2 data was collected 3 months after the participant
had exited IDVA services (T2N = 32 hospital; N = 4
community). Time 2 data were available for 36.0% of the
hospital IDVA sub-sample and 4.6% of the community
IDVA sub-sample. Owing to virtual absence of data from
the community IDVA sub-sample, only findings from the
hospital IDVA service were analysed and reported for
health outcomes.
SF12 Health Survey (Physical health composite score
(PCS) and Mental health composite score) (MCS) consists
of 12 items designed to measure and monitor health [24].
The 12 items map onto components reflecting physical
functioning, role limitations due to physical problems and
emotional problems, mental health, energy/vitality and
pain. Items measured on nominal / ordinal scales, are
totalled to produce two mean scores of physical health
(PCS12) and mental health (MCS12); where lower scores
represent lower health. Time 2 data were available for
31.6% of the T1 hospital IDVA sample (T1 n = 101; T2
n = 32).
HADS Hospital Anxiety and Depression Scale [25]
comprises 14 items assessed on a 4-point ordinal scale.
Seven items are totalled to produce mean scores for the
two component subscales measuring Anxiety and De-
pression. Scores of 0–7 suggest ‘normal’ levels of anxiety
or depression, 8–10 borderline ‘abnormal’, 11–21 ‘ab-
normal’. Time 2 data were available for 32.9% of the T1
hospital IDVA sample (T1 n = 97; T2 n = 32).
Primary Care Post-Traumatic Stress Disorder Screen
[26] is a 5-item measure that begins with an item
designed to assess whether the participant has had any
exposure to traumatic events over the course of their
life. If the answer is ‘No’ to this initial item, the PC-
PTSD-5 is completed with a score of 0. If the answer is
‘Yes’, five additional questions (yes, no) are asked about
how that trauma exposure has affected participants
over the past month. A score of 4+ indicates probable
symptomology in-line with a diagnosis of post-
traumatic stress disorder. Time 2 data were available
Halliwell et al. BMC Health Services Research          (2019) 19:718 Page 3 of 12
for 35.6% of the T1 hospital IDVA sample (T1 n = 73;
T2 n = 26).
Health Service use was recorded at T1 community
(n = 76) and hospital IDVA participants (n = 38) and T2
hospital participants only (n = 31); participants were
asked to recall their use of hospital services (inpatient,
outpatient, ED and ambulance), local and mental health
services and social care services over the previous 6
months or 6 months at T1 and T3 respectively.
Analysis
We tested differences between hospital and community
IDVA services, using the community IDVA data as the
comparator to our hospital data. The results of t-tests
and chi-square statistics are reported for comparison of
demographic variables. Non-parametric tests were used
to explore pre-and post-intervention outcomes (abuse
frequency and severity, cessation of abuse, safety, health
outcomes and health resource use) as the data was not
normally distributed, and median values were reported
in addition to mean values. Scores on the SF12 and
HADS scales were compared to population figures for
the UK [27, 28]. A multi-variate model was used to iden-
tify the factors associated with survivor’s appraisals of
safety and cessation of abuse for IDVA services. Covari-
ates correlated with ‘feelings of safety’ and ‘cessation of
abuse’ were included in the models. Examination of
variance inflation factor (VIF) and tolerance statistics
indicated multicollinearity for the outcome ‘cessation of
abuse’ but not for the model applied to ‘feelings of
safety’. Consequently, ordinal and logistic regression
techniques were used to identify factors which may
contribute to the outcome variable ‘feelings of safety’.
There were no differences in the two models, therefore
logistic regression findings have been reported for ease
of interpretation. This analysis was conducted on the
total sample which included men and women. Typically,
the experiences of men and women who experience
DVA tend to be different [29]. Bivariate analyses of the
regression models revealed no differences according to
gender, potentially owing to the small number of male
cases. A decision was taken to include men within the
samples as one of the key research questions was to
understand the difference in who was identified by
hospital IDVA services compared to community IDVA
services. Analyses dealt with missing data listwise which
reduced the sample size dramatically across some vari-
ables particularly within the community IDVA sub-
sample. This meant that some variables could not be
included in the analyses (documented in tables), to this
effect in addition to N’s ns’s have been reported. Health
resource unit costs were compiled from NHS Reference
Costs (2013/14) and Personal Social Services Research
Unit (PSSRU) [30, 31] (Additional file 1). Health service
use data in the 6 months pre IDVA intervention were
compared for hospital and community survivors, gener-
ating a cost to services. Owing to a lack of data at T2 (6
months post intervention) T1 and T2 comparisons could
only be made for hospital survivors. One survivor in the
hospital IDVA group was considered an outlier as she
alone counted for 29% of the ED visits and 40% of ambu-
lance trips. Results of the cost analysis are reported for the
entire sample and with exclusion of this outlier. This did
not affect the difference in the overall health service use
between hospital and community survivors. An estimate
of potential cost savings generated by hospital IDVAs was
performed and compared to the overall cost of setting up
hospital IDVA services (Additional file 1).
Results
Characteristics of survivors accessing hospital IDVA
services
Table 1 presents the demographic characteristics of sur-
vivors at the point of accessing hospital IDVA services
(T1) compared to those working with community IDVA
services. Most survivors supported by both services were
white British or Irish (84.2% hospital; 77.5% community),
heterosexual (98.0% hospital; 90.2% community) women
(93.6% hospital; 96.2% community) who were, on aver-
age, in their mid-thirties (M = 35.6, 95% CI 34.6 to 35.4;
hospital; M = 34.9, 95% CI 34.5 to 35.3 community). In
both settings, smaller numbers of black, Asian, minority
and ethnic groups (BAME) (15.3% hospital; 17.1%
community), men (5.1% hospital; 4.2% community) and
lesbian, gay, bisexual or transgender (LGBT) (2.0%
hospital; 2.2% community) survivors were identified.
Survivors working with hospital IDVAs were more likely
to be pregnant (17.1% hospital; 6.3% community) or not
have children at home (67.2% community; 51.1% hos-
pital). A higher proportion of hospital survivors were
aged over fifty-five (10.1% hospital; 6.8% community)
and came from higher-income households (salaries over
£36,400 per annum) (9.1% hospital; 4.2% community).
Hospital survivors reported higher levels of complex
needs and additional vulnerabilities including mental
health difficulties (57.3% hospital; 35.2% community),
alcohol (18.4% hospital; 8.3% community) and drug use
problems (11.2% hospital; 5.2% community), financial
difficulties (40.1%; hospital; 30.3% community) and dis-
ability (12.2% hospital; 8.3% community). Twice as many
hospital survivors had ever planned or attempted suicide
(36.3% hospital; 16.2% community) or had self-harmed
(43.5% hospital; 23.5% community).
In the 3 months before accessing IDVA services, survi-
vors in both settings experienced a high level of severe
physical abuse (46.6% hospital; 41.2% community), jeal-
ous controlling and coercive behaviours (47.3%; hospital;
47.1% community) and harassment or stalking (30.8%
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hospital; 34.1% community). For all survivors, this abuse
had escalated in severity and frequency within the last 3
months (57.2% hospital; 68.3% community). For commu-
nity IDVA services, this escalation was higher and com-
munity IDVAs were more likely to deem their cases at
higher risk of serious harm or fatality from the abuse
(53.1% hospital; 58.2% community). However, hospital
survivors were more likely to report severe forms of
sexual abuse in the previous 3 months (14.3% hospital;
10.2% community). At the point of engaging with hos-
pital IDVA services, survivors had experienced abuse for
shorter periods (abuse length in months; Mdn = 30.0,
IQR 60.1) compared with community services (Mdn =
36.3, IQR 70.0).
Community IDVAs tended to support survivors who
were experiencing abuse from an ex-partner (35.3%
hospital; 59.7% community). Hospital survivors were
more likely to experience abuse from a current intimate
partner (53.4% hospital; 31.6% community) or multiple
perpetrators (14.3% hospital; 8.3% community). Higher
proportions of hospital survivors were living with the
abuser at the point of referral (48.3% hospital; 29.7%
community). Despite being more likely to have been
abusive to other partners or family members (79.3%
hospital; 67.7% community), those perpetrating abuse
towards hospital survivors were less likely to have a
criminal record for DVA (36.6% hospital; 45.2%
community).
Identifying and referring survivors of domestic abuse
across healthcare settings
Table 2 presents the help-seeking behaviours reported
by hospital survivors compared with community survi-
vors in the 6 months preceding support from an IDVA
service. Those working with community IDVA services
Table 1 Characteristics of survivors accessing hospital and
community IDVA services at T1
Hospital IDVA Community
IDVA
% %
Gender (ns = 677, 3506)
Male 5.1 4.2
Female 93.6 96.2
Sexual orientation (ns = 678, 3527)
Lesbian/gay/bisexual 2.0 2.2
Heterosexual 98.0 90.2
Age (ns = 686, 3529)
M (SD) / [CI] 35.6 (13.1) [34.6,
35.4]
34.9 (11.8)
[34.5, 35.3]
Over 55a 10.1** 6.8
Ethnicity (ns = 689, 3523)
Black/minority ethnic 15.3 17.1
White/British/Irish 84.2 77.5
Relationship status (ns = 689, 3541)
Current partner 53.4*** 31.6
Ex-partner 35.3 59.7***
Children in the household (n = 692,
3544)
Children at home 51.1 67.2***
Pregnant 17.1*** 6.3
Household income (ns = 277, 1429)
High £34,000+ p.a. 9.1*** 4.2
Middle £33,999–15,599 p.a 15.1 12.4
Low 15,549 and below 49.4 55.3
Living arrangements (ns = 692, 3536)
Cohabiting 48.3*** 29.7
Living separately 43.4 62.2***
Survivors’ complex needs (ns = 667, 3474)
Alcohol misuse 18.4*** 8.3
Drug misuse 11.2*** 5.2
Financial difficulties 40.1*** 30.3
Disability 12.2*** 8.3
Mental health 57.3*** 35.2
Suicidal ideation / behaviours 36.3*** 16.2
Self-harm 43.5*** 23.5
Perpetrator information (ns = 686, 3545)
Previously abusive to family or other
partner
79.3*** 67.7
Previous criminal record for domestic
violence
36.6 45.2**
Multiple perpetrators 14.3*** 8.3
Length of time survivor experienced abuse (months) (n = 692, 3544)
Mdn (IQR) 30.0 (60.1) 36.3 (72)
Table 1 Characteristics of survivors accessing hospital and
community IDVA services at T1 (Continued)
Hospital IDVA Community
IDVA
% %
Type of abuse experienced (ns = 683, 3537)
Severe physical 46.6** 41.2
Severe sexual 14.3** 10.2
Severe controlling coercive behaviour 47.3 47.1
Severe harassment and stalking 30.8 34.1
Abuse that is escalating in severity or
frequency
57.2 68.3*
At high risk (professional judgement) 53.1 58.2*
*** p < .001,**p < .01, p < .05*
Note: Over 55a. T-test revealed no significant difference in mean age. Owing
to high variation in data, age was split across four age bandings according to
the distribution (< 18 to 21, 21 to 40, 40 to 55, 55>) and coded into ordinal
variables. Significance testing of data accordingly revealed differences in age
for those over 55+ between hospital and community IDVA services
Halliwell et al. BMC Health Services Research          (2019) 19:718 Page 5 of 12
were more likely to have called the police (77.2%) than
those supported by a hospital IDVA (58.7%); whereas,
hospital survivors had accessed a greater number of
health services for issues specifically related to DVA.
They were more likely to have visited their GP (88.3%
hospital; 77.2% community) and ED (56.2% hospital;
16% community). More hospital survivors had attended
ED by ambulance (37.3% hospital; 16.3% community)
than community survivors. Around a half (45.7%) of sur-
vivors identified by hospital IDVA services had done so
after an overdose or because of mental ill health (50.6%);
while 13.4% had visited ED because of physical injuries
from the abuser.
Analysis of referral routes into the hospital IDVA
service (Table 3) show that 84.6% of cases came from
other health services, mostly within the hospital itself.
ED played a key role in identifying survivors, accounting
for over half (62.3%) of hospital IDVA referrals, followed
by maternity and ante/neonatal units (16.8%) and psych-
iatry or mental health departments (7.3%). Nurses identi-
fied the greatest number of survivors (45.6%), followed
by consultants/doctors/junior doctors (18.2%), midwives
(13.7%) and psychiatrists/psychologists (8.4%). Compara-
tively, in community IDVA services, referrals were less
likely to come from health services (2.3%). At the point
of exiting the service, hospital IDVAs had helped survi-
vors to access a higher number of health-based services
than community IDVAs. Hospital survivors were more
likely to have been referred to mental health services
(22.9% hospital; 14.9%) and substance services (34.0%
hospital; 3.3% community); whereas, community IDVAs
referred higher proportions of survivors to the police
(52.1% hospital; 83.7%).
Length and type of support
Support provided by hospital IDVAs (Table 4) comprised
regular contact and access to a number of community
programmes and resources. On average, hospital survivors
were supported for just under 2 months (months Mdn =
1.7, IQR 2.7) which was shorter than support at commu-
nity services (months Mdn = 2.4, IQR 3.1). However, hos-
pital IDVAs worked as intensively as community IDVAs
over this period with both services delivering the same
number of face-to-face contacts with survivors (Mdn = 8.0
both hospital and community). Both IDVA services were
most likely to provide support around safety planning,
health and wellbeing, the police and housing. Survivors
working with hospital IDVAs were more likely to have
been helped to access safety planning (72.3% hospital;
63.4% community), health and wellbeing services (67.7%
hospital; 56.3% community), the police (47.8% hospital;
41.2% community) and housing (45.3% hospital; 31.4%
community). Hospital survivors were less likely than
community IDVA survivors to have been helped to access
civil orders (5.2% hospital; 14.3% community) or support
with the criminal courts (1.1% hospital; 4.4% community).
Table 2 Help-seeking behaviours 6 months before accessing an
IDVA service at T1
Hospital
IDVA
Community
IDVA
% %
Help seeking (ns = 488, 3211)
Saw GP for any reason 88.3*** 77.2
Called the police 58.7 77.2***
Attended Accident and Emergency as a
result of abuse
56.2*** 16.3
Attended ED by ambulance as a result of
the abuse
37.3** 16.2
Hospital IDVA survivors reasons for accessing ED (n = 103)a
Visit because of physical injuries of abuser 13.4 –
Visit for mental health reason 50.6 –
Visit to ED after an overdose 45.7 –
*** p < .001, **p < .01, p < .05*
aLarge amount of missing data for the community IDVA sample meant that
comparative figures could not be reported for these indicators
Table 3 Referral routes into hospital and community IDVA
services at intake (T1) and exit (T2)
Hospital
IDVA
Community
IDVA
% %
Referral route to IDVA service T1 (ns = 283, 2430)
Health 84.6*** 2.3
Police 9.6 45.3***
Self 2.2 23.4***
Hospital department referrals to hospital IDVA T1 (n = 170)a
ED 62.3 –
Maternity, ante- and neo-natal units 16.8 –
Psychiatry / mental health 7.3 –
Hospital staff referrals to hospital IDVA T1 (n = 164)a
Nurse 45.6 –
Consultant/Doctor/Junior Doctor 18.2 –
Midwife 13.7 –
Psychologist/Psychiatrist 8.4 –
Ward Sister 4.5 –
Referral route out of IDVA service T2 (ns =
476, 2430)
52.1 83.7***
Police 66.0*** 15.3
Housing 22.9* 14.9
Mental health 34.0** 3.3
Substance services 3.2 1.6
Adult social services
*** p < .001,**p < .01, p < .05*
aThis information was only collected for survivors accessing the hospital
IDVA service
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Health outcomes
Health measures at the point of accessing a service (T1)
demonstrated that hospital IDVAs worked with survi-
vors who reported poorer physical health (T1M = 49.2,
95% CI 47.1 to 53.9) and substantially poorer mental
health (T1M = 32.3, 95% CI 29.5 to 34.2) compared with
the general UK population (Table 5). Among hospital.
survivors, levels of anxiety (T1M = 12.2, 95% CI 10.6
to 13.5) and depression (T1M = 10.5, 95% CI 7.9 to
12.2) were twice the national average. At T1, over half
(62.6%) screened positive for Post-Traumatic Stress
Disorder (PTSD) (T1M = 2.1, 95% CI 1.7 to 2.5). Be-
tween T1 and T2 (3 months after exiting support for
DVA), no changes were observed in health outcomes
among hospital survivors. While survivors reported a
lower level of physical (T2M = 48.7, 95% CI 45.9 to
54.0) and mental health concerns at T2 (T2M = 39.6,
95% CI 34.9 to 44.3), specifically around anxiety (T2
M = 11.4, 95% CI 10.6 to 12.6), depression (T2M = 8.6,
95% CI 7.9 to 10.0) and PTSD symptomology (T2M =
2.0, 95% CI 1.4 to 2.6), no significant differences were
observed; potentially owing to the small sample size.
DVA outcomes
Outcomes relating to the change in DVA assessed at the
closure of cases revealed some positive changes in safety
for survivors accessing both IDVA services (Table 6).
Survivors accessing hospital IDVA services were more
likely to experience cessation of abuse at the point of
exiting the service than survivors identified by commu-
nity IDVA services (62.4% hospital; 48.3% community).
Hospital survivors reported a higher level of reduction in
physical abuse (86.2% hospital; 71.2% community), sexual
abuse (82.4% hospital; 73.3% community), harassment and
stalking (75.6% hospital; 52.4% community) and jealous
coercive and controlling behaviours (70.1% hospital; 52.2%
community). Hospital survivors were more likely to report
that they felt ‘much safer’ (54.2%) compared to survivors
who accessed a community service (50.1%). Across both
services, several survivors reported a continuation of abuse
at exit. Abuse was ongoing in 10.2% of hospital IDVA
cases and 18.4% of community IDVA cases.
Table 7 presents the results of logistic regression ana-
lyses examining the association between the different
resources / programmes received and reported safety
among survivors who accessed IDVA services, control-
ling for potentially confounding variables. Analyses
showed that safety increased if the support provided was
more intensive. Survivors who had accessed a hospital
IDVA service were two times more likely to report feel-
ing safer at case closure (AOR = 2.03, 95% CI 1.18 to
3.49) if they had received over five or more contacts with
an IDVA. Similarly, survivors accessing the hospital
Table 4 Support provided to survivors accessing hospital and
community IDVA services at T2
Hospital IDVA Community IDVA
Case length (N = 521, 2259)
Mdn (IQR) in months 1.7 (2.7) 2.4 (3.1)***
Frequency of contact with IDVA (ns = 533, 2376)
Mdn (IQR) 8.0 (9.0) 8.0 (11.0)
% < 5 contacts 21.2 40.6
% > 5 contacts 78.4 60.3
Types of support accessed (ns = 692, 2722)
% Safety planning 72.3*** 63.4
% Health and wellbeing 67.7*** 56.3
% Police 47.8* 41.2
% Housing 45.3*** 31.4
% Marac 34.4 32.3
% Children 24.5 24.6
% Finance / benefits 17.2* 13.2
% Civil orders 5.2 14.3***
% Probation 3.3 5.1
% Criminal court 1.1 4.4***
*** p < .001, **p < .01, p < .05*
Table 5 Health outcomes for survivors accessing hospital IDVA services T1 compared with T2
Time one (T1) Time two (T2) UK population
Health measures hospital IDVA sample
(n = 64, 21)
M SD / [95% CI] M SD / [95% CI] M SD
Physical health (SF12-PCS) 49.2 12.8 [47.1, 53.9] 48.7 11.4 [45.9, 54.0] 50.9 9.4
Mental health (SF12 - MCS) 32.3 12.2 [29.5, 34.2] 39.6 12.8 [34.9, 44.3] 52.1 8.7
Anxiety (HADS - Anxiety) 12.2 5.1 [10.6,13.5] 11.4 6.3 [10.6,12.6] 6.7a 4.2
Depression (HADS - Depression) 10.5 5.2 [7.9, 12.2] 8.6 6.1 [7.9, 10.0] 5.5* 4.0
Post-Traumatic Stress Disorder (PTSD) % %
62.6 48.6
M (SD) / [95% CI] 2.1 1.65 [1.7, 2.5] 2.0 1.5 [1.4, 2.6]
a UK normative data for females [56]. Women score higher on anxiety scales, no significant differences in depression between men and women
Note. No statistical differences were found between T1 and T2 for health outcomes; all measures = p < NS
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IDVA service were found to have higher odds of achiev-
ing feelings of safety if they had been supported over a
longer period and had accessed a higher number of
resources / programmes provided by wider community
services. Accessing six or more resources / programmes
increased safety by one and a half times AOR = 2.38,
95% CI 1.41 to 3.87) and odds of achieving this outcome
increased progressively with a greater number of support
days provided by the IDVA (AOR = 2.00, 95% CI 1.00 to
1.01). Survivors who had accessed a hospital IDVA
service were more likely to report no change or feeling
less safe at exit if they had experienced suicidal ideation
or behaviours at the point of initial referral (AOR = 2.00,
95% CI 0.28 to 0.74). The same model was applied to
the community IDVA cases and findings were replicated,
whereby, feelings of safety were increased in line with
more intensive support in terms of more frequent con-
tact with a community IDVA (AOR = 1.45, 95% CI 1.12
to 1.89) and access to a range of resources / programmes
(AOR = 1.82, 95% CI = 1.43 to 2.31).
Health resource use and cost analysis
In the 6 months before accessing IDVA services, hospital
survivors used more health services than community
survivors (Table 8). In terms of single components, dif-
ferences were observed for general practices (hospital
M = 4.9, 95% CI 3.7 to 6.0; community M = 2.6, 95% CI
1.8 to 3.9), mental health services (counsellors) (hospital
M = 3.0, 95% CI 0.4 to 6.4; community M = 1.5, 95% CI
0.0 to 3.0), inpatient stays (hospital M = 3.6, 95% CI 1.2
to 6.0; community M = 0.3, 95% CI 0.0 to 0.7), ED
attendance (hospital M = 1.0, 95% CI 0.6 to 1.3; commu-
nity M = 0.4, 95% CI 0.1 to 0.5) and ambulance trips
(hospital M = 0.6, 95% CI 0.3 to 0.1; community M = 0.2,
95% CI 0.0 to 0.3). The cost analysis based on health
resource use showed that hospital survivors cost on
average £2248 (95% CI £1646 to £2977) and community
survivors cost on average £533 (95% CI £373 to £713).
Based on the difference in resource use 6 months
before (T1) and 6 months after (T2) accessing the
hospital IDVA service, a cost reduction was observed
post-intervention in most hospital services. Hospital
survivors reported fewer inpatient stays (T1M = 4.5, 95%
CI 0.8 to 10.0; T2M = 0.0), ED attendances (T1M = 0.9,
95% CI 0.3 to 1.4; T2M = 0.4, 95% CI 0.0 to 0.7) and
ambulance trips (T1M = 0.6, 95% CI 0.0 to 1.0; T2M =
0.1, 95% CI 0.0 to 0.3). Outpatient appointments in-
creased pre and post intervention (T1M = 0.8, 95% CI
0.3 to 1.1; T2M = 2.7, 95% CI 0.3 to 5.0). Decreased use
of hospital services offset the increase in cost observed
in slightly higher levels of attendance at general practices
(T1M = 4.0, 95% CI 2.5 to 5.8; T2M = 5.3, 95% CI 3.4 to
7.2), mental health services (community psychiatric
nurse) (T1M = 4.0, 95% CI 2.5 to 5.8; T2M = 5.3, 95%
CI 3.4 to 7.2) and substance services (T1M = 1.1, 95%
CI 0.1 to 2.3; T2M = 1.5, 95% CI 0.4 to 3.4). However,
the only significant difference in health service use pre
and post intervention was attributed to the decrease in
hospital inpatient stays; potentially owing to the small
sample size. Overall, the cost reduction post intervention
was equivalent to savings of £2050 per patient per year
when the resource use is extrapolated to a one-year
period (6 months £1025, 95% CI £182 to £2030).
Discussion
This article reports findings from a multi-site evaluation
of a healthcare-based advocacy intervention which co-
located IDVAs in five UK hospitals. Results highlight the
advantages of placing IDVAs within ED and maternity
departments compared to community IDVA services.
Earlier intervention and support for ‘hidden’ survivors
Hospital IDVA services enabled access to support for sur-
vivors less visible to community IDVA services. Although
referrals for some such survivors -- BAME people, LGBT
Table 6 DVA outcomes and reductions in abuse for survivors
accessing hospital and community IDVA services
Hospital
IDVA
Community
IDVA
DVA outcomes at T2 % %
Cessation of abuse (ns = 476, 2722)
% ceased 62.4** 48.3
% ongoing 10.2 18.4
% don’t’ know / missing 27.4 33.3
Reductions in reported abuse
% reporting physical abuse 86.2** 71.2
% reporting sexual abuse 82.4* 73.3
% reporting harassment and stalking 75.6** 52.4
% reporting jealous coercive and
controlling behaviour
70.1* 52.2
Survivor appraisal of safety
% much safer than before 54.2* 50.1
% somewhat safer than before 30.1 36.4
% no safer than before 7.2 9.1
% don’t know/missing 8.5 4.4
Reductions in abuse between T1 & T2
Report of abuse between intake and exit
(ns = 476, 2722)
T1 T2 T1 T2
% physical abuse 70.3 10.2*** 60.3 18.4**
% sexual abuse 25.4 5.3*** 19.2 5.8***
% harassment and stalking 66.6 17.4** 62.2 30.1*
% jealous coercive and controlling
behaviour
87.5 18.5* 85.4 40.2*
*** p < .001,**p < .01, p < .05*
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people, and men -- were low, hospital IDVAs worked with
survivors who were older (aged over 55), from higher
income households and who were pregnant. This mirrors
previous research [20, 21]. Our findings highlight that hos-
pital IDVAs were more likely to engage with survivors at
an earlier point in the abusive relationship, often when
survivor and perpetrator were still living together. This
demonstrates hospital IDVA services may provide an
opportunity for earlier intervention.
Integration within the hospital community
In line with previous research, survivors accessing hos-
pital IDVA services were more likely to see their GP and
attend ED for issues related to DVA in the 6 months
preceding support but were less likely to call the police
[7, 8]. The number of survivors presenting to ED
particularly by ambulance demonstrates the need for
paramedics and ED healthcare professionals to be
trained in effectively responding to DVA. A key compo-
nent of the hospital IDVA role was to raise awareness of
DVA services within the hospital community and pro-
vide training to healthcare professionals. The analysis of
referral routes into IDVA services shows the advantages
of this aspect of the service, with increased referrals into
the hospital IDVA from a range of hospital departments.
Similarly, hospital IDVAs enabled a greater number of
survivors to access ongoing health services (e.g., mental
health and substance services) at the point of case clos-
ure. Reflecting existing research, this suggests that the
co-location of IDVAs in hospitals provides clear referral
pathways for survivors to specialist DVA support that is
immediately accessible but also other health services for
longer term care [19–21].
Outcomes for survivors
By case closure, most survivors reported reductions in
all forms of abuse and over half felt safer. Survivors
engaging with hospital IDVA services were more likely
to experience cessation of abuse and greater reductions
in abuse from T1 to T2 than survivors accessing com-
munity IDVA services. However, within the community
IDVA service abuse tended to be more severe at intake,
potentially leading to lower reductions in non-physical
forms of abuse at the point of exit. In line with previous
Table 7 Factors influencing feelings of safety after accessing hospital and community IDVA services at T2
Hospital IDVA - Survivor felt safer (1) vs not
safer/missing (0)
Community IDVA - Survivor felt safer (1) vs not
safer/missing (0)
95% C.I.for
EXP(B)
95% C.I.for
EXP(B)
B S.E. Wald df Sig. AOR Lower Upper B S.E. Wald df Sig. AOR Lower Upper
6+ interventions accessed (1) vs 0–1 accessed
(0)
.84 .25 10.8 1 .001 2.3 1.4 3.8 .59 .12 23.903 1 .000 1.8 1.4 2.3
5+ contacts with IDVA (1) vs < 5 (0) .71 .27 6.6 1 .010 2.0 1.2 3.4 .37 .13 8.034 1 .005 1.4 1.1 1.8
Length of case (days) .00 .00 7.0 1 .008 1.0 1.0 1.0 .00 .00 .011 1 .917 1.0 .99 1.0
Reported suicidal ideation/behaviour T1 (1) vs
none recorded (0)
−.77 .24 10.2 1 .001 .46 .28 .74 −.19 .15 1.481 1 .224 .82 .60 1.1
Any abuse escalating in severity and frequency
at T1 (1) vs none recorded (0)
−.36 .29 1.5 1 .219 .69 .38 1.2 .20 .13 2.143 1 .143 1.2 .93 1.5
Physical abuse at T1 (1) vs none recorded (0) −.07 .27 .08 1 .775 .92 .53 1.5 −.12 .12 .913 1 .339 .88 .68 1.1
Harassment and stalking at T1 (1) vs none
recorded (0)
−.08 .25 .10 1 .752 .92 .56 1.5 −.00 .11 .002 1 .968 .99 .78 1.2
Jealous coercive and controlling behaviour at T1
(1) vs none recorded (0)
.11 .36 .10 1 .750 1.1 .54 2.3 −.10 .16 .388 1 .533 .90 .66 1.2
Drug/alcohol misuse at T1 (1) vs none recorded
(0)
−.04 .32 .02 1 .897 .95 .50 1.8 −.05 .22 .049 1 .825 .95 .60 1.4
Mental health issues at T1 (1) vs none recorded
(0)
−.48 .36 1.7 1 .186 .61 .29 1.2 −.51 .25 4.023 1 .045 .59 .36 .98
Perpetrator drug/alcohol misuse at T1 (1) vs
none recorded (0)
−.39 .37 1.1 1 .292 .67 .32 1.3 .15 .18 .769 1 .381 1.1 .82 1.6
Perpetrator mental health at T1 (1) vs none
recorded (0)
.36 .40 .81 1 .368 1.4 .65 3.1 .09 .18 .268 1 .605 1.1 .76 1.5
Perpetrator financial issues at T1 (1) vs none
recorded (0)
−.33 .40 .68 1 .408 .71 .32 1.5 −.05 .18 .073 1 .787 .95 .66 1.3
Constant .41 .43 .93 1 .333 1.5 .94 .20 22.2 1 .000 2.5
Hospital n = 451; Model statistics: -2LL = 471.46, X2 = 57.06, df = 13, p < .001, Nagelkerke R2 = .17, % classified correctly = 75%
Community n = 2177; Model statistics: -2LL = 1877.80, X2 = 142.96, df = 13, p < .001, Nagelkerke R2 = .16, % classified correctly = 81%
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research, intensive support from IDVAs (five or more
contacts) over a longer period and access to a greater
number of community resources / programmes increased
the likelihood of safety [17, 18]. These results demonstrate
the importance of hospital-IDVAs working as part of a
co-ordinated multi-agency response.
No changes were observed in health outcomes for
survivors who had accessed the hospital IDVA. These
findings may reflect the small size of the sample or the
short time period at which health outcomes were
assessed after case closure. However, 3 months after
accessing support, reported levels of health were still
proportionately lower than UK averages. Survivors
accessing hospital IDVA services experienced dimin-
ished odds of feeling safe if at the point of intake they
were experiencing suicidal thoughts / behaviours. Given
the high proportion of mental health issues among this
population, the continued presence of mental health
services is particularly vital.
Financial implications of hospital IDVA
The cost of providing hospital IDVA services may be ~
£315–£417 per survivor per year (Additional file 1).
When compared to the potential cost savings associated
with the intervention, providing hospital IDVA services
would be cost-neutral for the NHS. For hospitals them-
selves, the intervention could be particularly cost-effective
as the main reduction in costs after the intervention was
entirely associated with hospital services.
Limitations
There were several limitations relating to the evaluation
design and data quality. The design was nonexperimen-
tal, which may have resulted in the overstatement of
Table 8 Health resource use at T1 compared with T2 (hospital survivors only)
Hospital survivors n = 76 Community survivors
n = 38
Hospital survivors T1
n = 29
Hospital survivors T2 n = 29
Health resource M
use
SD / 95%
CI
M
cost
M
use
SD / 95%
CI
M
cost
M
use
SD / 95%
CI
M
cost
M
use
SD / 95%
CI
M
cost
Diff. T1 - T2
GP surgery consultation 4.9** 4.9 [3.7,
6.0]
239 2.9 3.2 [1.8,
3.9]
142 4.0 4.3 [2.5, 5.8] 198 5.3 4.9 [3.4,
7.2]
261 -£63
GP phone consultation 1.3 4.2 [0.3,
2.3]
27 0.5 1.2 [0.1,
0.9]
10 1.8 5.6 [0.2, 4.0] 37 1.2 2.2 [0.3,
2.0]
24 £13
Practice Nurse
consultation
2.0 7.4 [0.2,
3.6]
24 0.7 1.5 [0.3,
1.2]
9 1.5 4.8 [0.2, 3.4] 19 1.1 2.0 [0.3,
1.9]
14 £5
Community Psychiatric
Nurse
0.9 2.8 [0.2,
1.5]
33 0.0 0.2 [0.03,
0.8]
1 0.7 2.7 [0.3, 1.8] 28 1.7 5.4 [0.3,
3.6]
63 -£35
Psychiatrist 0.4 1.2 [0.1,
0.7]
45 0.0 0.2 [0.03,
0.8]
3 0.5 1.2 [0.0, 0.9] 50 0.9 4.3 [0.7,
2.5]
100 -£50
Clinical Psychologist 0.8 3.8 [0.1,
1.6]
160 – – – 1.5 5.9 [0.7, 3.8] 325 1.7 5.5 [0.4,
3.7]
353 -£28
Health Visitor 2.0 9.2 [0.2,
4.9]
106 1.0 3.0 [0.3,
1.9]
53 0.7 1.9 [0.0, 1.5] 38 0.5 1.8 [0.2,
1.1]
25 £13
Counsellor 3.0** 14.6 [0.4,
6.4]
138 1.5 4.6 [0.0,
3.0]
69 2.0 6.8 [0.5, 4.6] 92 2.1 5.3 [0.1,
4.1]
98 -£6
Psychotherapist 0.1 0.9 [0.1,
0.3]
17 0.0 – – 0.3 1.4 [0.3, 0.8] 42 0.0 – 0 £42
Family therapist 0.0 – – 0.1 0.3 [0.0,
0.1]
8 0.0 – 0 0.1 0.7 [0.1,
0.4]
21 -£21
Drug/alcohol support 0.9 3.5 [0.0,
1.6]
66 0.2 0.7 [0.0,
0.4]
12 1.1 3.2 [0.1, 2.3] 83 1.5 5.0 [0.4,
3.4]
120 -£37
In-patient stay per night 3.6** 10.3 [1.2,
6.0]
997 0.3** 1.2 [0.0,
0.7]
94 4.5 14.2 [0.8,
10.0]
1238 0.0** – 0 £1238
Outpatient
appointments
1.3 2.4 [0.7,
1.7]
142 0.4 1.2 [0.0,
0.8]
50 0.8 1.9 [0.3, 1.1] 93 2.7 6.2 [0.3,
5.0]
296 -£203
A&E attendance 1.0** 1.4 [0.6,
1.3]
118 0.4 0.6 [0.1,
0.5]
46 0.9 1.4 [0.3, 1.4] 107 0.4 0.9 [0.0,
0.7]
50 £57
Ambulance trip 0.6* 1.3 [0.3,
0.1]
136 0.2* 0.4 [0.0,
0.3]
36 0.6 1.4 [0.0, 1.0] 131 0.1 0.5 [0.0,
0.3]
31 £100
Total (95% CI) £2248 (£1646 to
£2977)
£533 (£373 to
£713)
£2481 (£1731 to
£3629)
£1456 (£192 to
£2063
£1025 (£182 to
£2030)
*** p < .001,**p < .01, p < .05*
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intervention effectiveness [32]. The DVA outcome meas-
ure (feelings of safety) was a self-reported single-item
and included no measure of attribution. Owing to high
levels of attrition at T2 determining health outcomes for
survivors accessing community IDVA services was not
possible. The cost analysis was limited as the resource
use estimates were based on patient recollection. The
sample size was limited, especially the hospital partici-
pants sample informing the pre- and post-intervention
cost analysis. The analysis did not attempt to quantify
the cost-effectiveness of the intervention due to the
limited data available. Further research is required to
support the efficacy of this intervention, ideally adopting
an experimental design, using robust and validated
outcome measures of DVA, with cost-effectiveness and
health outcomes assessed over an extended time frame.
Conclusion
Healthcare based interventions represent a specific ap-
proach to identifying, preventing and managing DVA in a
location that survivors are likely to visit due to the range of
health impacts that accompany experiences of abuse.
Findings discussed here indicate that co-locating specialist
domestic violence advocacy services (IDVAs) in hospitals
can help healthcare professionals to identify abuse among
their patients with the option to refer immediately for
support. The advantages of locating IDVAs in hospitals
include greater visibility of ‘hidden survivors’, an opportun-
ity to intervene earlier and increased referrals from health
services. Intensive support and access to community inter-
ventions were shown to have a positive impact on DVA
outcomes. This study has shown that hospital IDVAs offer
a unique and promising strategy for tacking DVA from
within the healthcare service.
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